We are live on ! Find out more
NVO

Novo Nordisk

505 hedge funds and large institutions have $10.7B invested in Novo Nordisk in 2015 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 181 increasing their positions, 179 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more call options, than puts

Call options by funds: $36.4M | Put options by funds: $8.25M

78% more funds holding in top 10

Funds holding in top 10: 1832 (+14)

33% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 42

25% more capital invested

Capital invested by funds: $8.56B → $10.7B (+$2.17B)

1% more funds holding

Funds holding: 500505 (+5)

1% more repeat investments, than reductions

Existing positions increased: 181 | Existing positions reduced: 179

0.11% less ownership

Funds ownership: 19.06%18.96% (-0.11%)

Holders
505
Holders Change
+5
Holders Change %
+1%
% of All Funds
13.46%
Holding in Top 10
32
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+77.78%
% of All Funds
0.85%
New
56
Increased
181
Reduced
179
Closed
42
Calls
$36.4M
Puts
$8.25M
Net Calls
+$28.2M
Net Calls Change
+$28.3M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
101
Autus Asset Management
Arizona
$7.93M +$1.01M +43,820 +17%
Brown Advisory
102
Brown Advisory
Maryland
$7.9M -$1.71M -74,064 -20%
SC
103
Scotia Capital
Ontario, Canada
$7.67M +$113K +4,886 +2%
GC
104
Guggenheim Capital
Illinois
$7.51M -$556K -24,156 -8%
DWM
105
Destination Wealth Management
California
$7.12M +$6.14M +266,734 New
JFL
106
Jarislowsky, Fraser Ltd
Quebec, Canada
$7.07M -$56.9K -2,470 -0.9%
PM
107
Penbrook Management
New York
$7.04M +$18.4K +800 +0.3%
JG
108
Jefferies Group
New York
$6.86M +$5.56M +241,252 +1,532%
HL
109
HeadInvest LLC
Maine
$6.79M +$52.9K +2,296 +0.9%
Capital Fund Management (CFM)
110
Capital Fund Management (CFM)
France
$6.6M -$7.55K -328 -0.1%
CCM
111
Carderock Capital Management
Maryland
$6.58M -$758K -32,936 -12%
TNB
112
Thomasville National Bank
Georgia
$6.52M +$112K +4,872 +2%
PA
113
Pinnacle Associates
New York
$6.35M +$210K +9,110 +4%
DADC
114
D.A. Davidson & Co
Montana
$6.32M -$1.68M -72,900 -24%
GC
115
Gratry & Company
Ohio
$6.26M +$3.35M +145,368 +163%
VAM
116
Vontobel Asset Management
New York
$6.23M +$825K +35,810 +18%
PCM
117
Palisade Capital Management
New Jersey
$6.09M
BFM
118
Boston Financial Management
Massachusetts
$6M -$8.29K -360 -0.2%
GF
119
Goodman Financial
Texas
$5.94M -$36.6K -1,590 -0.7%
NPA
120
Nichols & Pratt Advisers
Massachusetts
$5.92M +$135K +5,874 +3%
CW
121
Cobiz Wealth
Colorado
$5.91M -$104K -4,532 -2%
JHIU
122
Janus Henderson Investors US
Colorado
$5.82M +$4.22M +183,308 +528%
SB
123
Suntrust Banks
Georgia
$5.75M +$180K +7,814 +4%
WAM
124
World Asset Management
Michigan
$5.72M -$47.4K -2,060 -1%
FMT
125
First Mercantile Trust
Tennessee
$5.66M -$251K -10,898 -5%

NVO Hedge Fund Activity: Q1 2015 in Review

505 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2015, worth a combined $10.7B — up 25% from $8.56B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new NVO positions and 42 closed out — a net gain of 14 holders — while 181 added to existing stakes and 179 trimmed.

The largest buyer was Ameriprise, adding an estimated $181M. The largest seller was Arrowstreet Capital, cutting an estimated $114M.

  • 505 institutional investors held Novo Nordisk (NVO) as of Q1 2015, up from 500 in Q4 2014.
  • Funds reported $10.7B of Novo Nordisk stock for Q1 2015, up 25% quarter-over-quarter.
  • 56 funds opened new Novo Nordisk positions in Q1 2015 and 42 closed out, a net change of +14 holders.
  • The largest Novo Nordisk buyer in Q1 2015 was Ameriprise, an estimated $181M added.
  • The largest Novo Nordisk seller in Q1 2015 was Arrowstreet Capital, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2015.